Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood
Status:
Withdrawn
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a Randomized double blind trial with the aim to estimate the effectiveness of 3
therapeutic regimes per os on migraine pain:
- metoclopramide 0,15 mg/kg + placebo
- metoclopramide 0,15 mg/Kg + ketoprofen 1 mg/kg
- ketoprofen 1 mg/Kg + placebo
Intensity of pain will be measured with linear 1-10 scale or analogic McGrath type scale
every 20 min.
The main objective is the evaluation of healing times from pain in the 3 groups